Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Access anti-HBc Total

K-Number: K253687 · 2026-02-19

Decision Date2026-02-19
Product CodeSEI
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

Access anti-HBc Total is a medical device manufactured by Beckman Coulter, Inc.. It received FDA 510(k) clearance on 2026-02-19 under approval number K253687. The device is classified under product code SEI. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Access anti-HBc Total?

Access anti-HBc Total is a medical device that received FDA 510(k) clearance on 2026-02-19. It is manufactured by Beckman Coulter, Inc.. The 510(k) number is K253687.

When was Access anti-HBc Total approved by the FDA?

Access anti-HBc Total received FDA 510(k) clearance on 2026-02-19, under approval number K253687.

What company makes Access anti-HBc Total?

Access anti-HBc Total is manufactured by Beckman Coulter, Inc..

What is the FDA product code for Access anti-HBc Total?

The FDA product code for Access anti-HBc Total is SEI.

Related Clinical Trials

Other Devices by Beckman Coulter, Inc.

View all 77 devices →

Related Devices (Code: SEI)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.